Clinical Trial Update: Low Molecular Weight Heparin for Hemodialysis Anticoagulation [NA]

View source ↗

Summary

This update notes the completion of a clinical trial evaluating low molecular weight heparin for anticoagulation during hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: End Stage Renal Failure on Dialysis | NA | Status: COMPLETED